Blueprint Medicines
BPMC
S$166.69
Share price
0.00%
Change (1 day)
12.58%
Change (1 year)
Categories
EPS for Blueprint Medicines (BPMC)
EPS in 2025 (TTM): S-$3.29
According to Blueprint Medicines 's latest financial reports the company's current EPS (TTM) is S-$3.18. In 2024 the company made an earnings per share (EPS) of S-$1.33 an increase over its 2023 EPS that were of S-$10.76.
EPS history for Blueprint Medicines from 2015 to 2025
Annual EPS
| Year | EPS | Change |
|---|---|---|
| 2025 (TTM) | S-$3.29 | 147.92% |
| 2024 | S-$1.33 | -87.68% |
| 2023 | S-$10.76 | -10.59% |
| 2022 | S-$12.04 | -14.85% |
| 2021 | S-$14.14 | -297.13% |
| 2020 | S$7.17 | -176.3% |
| 2019 | S-$9.40 | 35.19% |
| 2018 | S-$6.95 | 38.82% |
| 2017 | S-$5.01 | 47.35% |
| 2016 | S-$3.40 | 9.25% |
| 2015 | S-$3.11 |
EPS for similar companies or competitors
| Company | EPS | EPS differencediff. | Country |
|---|---|---|---|
 Isoray
ISR | S-$0.09013 | -97.17% | 🇺🇸 USA |
 OPKO Health
OPK | S-$0.06438 | -97.98% | 🇺🇸 USA |
 Pacific Biosciences
PACB | S-$2.95 | -7.29% | 🇺🇸 USA |